Merck Cash on Hand 1986-2025 | MRK

Merck cash on hand from 1986 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  • Merck cash on hand for the quarter ending June 30, 2025 was $8.622B, a 24.06% decline year-over-year.
  • Merck cash on hand for 2024 was $13.689B, a 92.99% increase from 2023.
  • Merck cash on hand for 2023 was $7.093B, a 46.23% decline from 2022.
  • Merck cash on hand for 2022 was $13.192B, a 62.94% increase from 2021.
Merck Annual Cash on Hand
(Millions of US $)
2024 $13,689
2023 $7,093
2022 $13,192
2021 $8,096
2020 $8,050
2019 $10,450
2018 $8,864
2017 $8,498
2016 $14,341
2015 $13,427
2014 $15,719
2013 $17,486
2012 $16,141
2011 $14,972
2010 $12,201
2009 $9,604
2008 $5,486
2007 $8,231
2006 $8,713
2005 $15,638
2004 $7,090
2003 $4,173
2002 $4,971
2001 $3,287
2000 $4,255
1999 $3,202
1998 $3,356
1997 $2,309
1996 $2,182
1995 $3,350
1994 $2,270
1993 $1,542
1992 $1,094
1991 $1,412
1990 $1,197
1989 $1,144
1988 $1,550
1987 $1,148
1986 $966
1985 $842
Merck Quarterly Cash on Hand
(Millions of US $)
2025-06-30 $8,622
2025-03-31 $9,228
2024-12-31 $13,689
2024-09-30 $14,593
2024-06-30 $11,354
2024-03-31 $5,619
2023-12-31 $7,093
2023-09-30 $8,773
2023-06-30 $6,378
2023-03-31 $10,387
2022-12-31 $13,192
2022-09-30 $11,248
2022-06-30 $10,128
2022-03-31 $8,928
2021-12-31 $8,096
2021-09-30 $10,016
2021-06-30 $8,575
2021-03-31 $6,981
2020-12-31 $8,050
2020-09-30 $7,356
2020-06-30 $11,103
2020-03-31 $7,432
2019-12-31 $10,450
2019-09-30 $8,018
2019-06-30 $7,105
2019-03-31 $8,798
2018-12-31 $8,864
2018-09-30 $10,285
2018-06-30 $7,594
2018-03-31 $7,346
2017-12-31 $8,498
2017-09-30 $11,195
2017-06-30 $11,967
2017-03-31 $15,249
2016-12-31 $14,341
2016-09-30 $13,067
2016-06-30 $11,834
2016-03-31 $12,943
2015-12-31 $13,427
2015-09-30 $12,089
2015-06-30 $11,370
2015-03-31 $15,601
2014-12-31 $15,719
2014-09-30 $14,347
2014-06-30 $13,395
2014-03-31 $20,513
2013-12-31 $17,486
2013-09-30 $18,169
2013-06-30 $18,098
2013-03-31 $16,022
2012-12-31 $16,141
2012-09-30 $18,117
2012-06-30 $17,450
2012-03-31 $15,566
2011-12-31 $14,972
2011-09-30 $15,576
2011-06-30 $13,981
2011-03-31 $13,029
2010-12-31 $12,201
2010-09-30 $10,625
2010-06-30 $9,943
2010-03-31 $9,777
2009-12-31 $9,604
2009-09-30 $22,256
2009-06-30 $16,932
2009-03-31 $12,582
2008-12-31 $5,486
2008-09-30 $6,841
2008-06-30 $9,988
2008-03-31 $9,164
2007-12-31 $8,231
2007-09-30 $7,392
2007-06-30 $5,504
2007-03-31 $4,056
2006-12-31 $8,713
2006-09-30 $9,087
2006-06-30 $10,464
2006-03-31 $12,402
2005-12-31 $15,638
2005-09-30 $14,028
2005-06-30 $13,031
2005-03-31 $9,438
2004-12-31 $7,090
2004-09-30 $6,957
2004-06-30 $6,177
2004-03-31 $5,312
2003-12-31 $4,173
2003-09-30 $6,293
2003-06-30 $5,716
2003-03-31 $5,137
2002-12-31 $4,971
2002-09-30 $3,985
2002-06-30 $3,110
2002-03-31 $4,506
2001-12-31 $3,287
2001-09-30 $3,849
2001-06-30 $3,960
2001-03-31 $4,000
2000-12-31 $4,255
2000-09-30 $2,835
2000-06-30 $3,912
2000-03-31 $3,293
1999-12-31 $3,202
1999-09-30 $3,780
1999-06-30 $3,541
1999-03-31 $3,096
1998-12-31 $3,356
1998-09-30 $4,015
1998-06-30 $2,794
1998-03-31 $2,809
1997-12-31 $2,309
1997-09-30 $2,167
1997-06-30 $2,716
1997-03-31 $2,599
1996-12-31 $2,182
1996-09-30 $2,352
1996-06-30 $2,515
1996-03-31 $3,466
1995-12-31 $3,350
1995-09-30 $2,917
1995-06-30 $2,601
1995-03-31 $3,045
1994-12-31 $2,270
1994-09-30 $2,406
1994-06-30 $2,173
1994-03-31 $1,627
1993-12-31 $1,542
1993-09-30 $1,801
1993-06-30 $1,395
1993-03-31 $1,158
1992-12-31 $1,094
1992-09-30 $1,364
1992-06-30 $1,059
1992-03-31 $1,133
1991-12-31 $1,412
1991-09-30 $1,598
1991-06-30 $1,291
1991-03-31 $1,251
1990-12-31 $1,197
1990-09-30 $1,168
1990-06-30 $1,092
1990-03-31 $963
1989-12-31 $1,144
1989-09-30 $1,308
1989-06-30 $1,217
1989-03-31 $1,696
1988-12-31 $1,550
1988-09-30 $1,455
1988-06-30 $1,248
1988-03-31 $1,122
1987-12-31 $1,148
1987-09-30 $1,380
1987-06-30 $1,152
1987-03-31 $1,124
1986-12-31 $966
1985-12-31 $842
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $270.018B $59.283B
Merck & Co. boasts more than six blockbuster drugs in its portfolio with PD-L1 inhibitor, Keytruda, approved for several types of cancer. Keytruda has played an instrumental role in driving Merck's steady revenue growth in the past few years. Well-known products in Merck's portfolio include Keytruda, Simponi , Januvia and Janumet, Bridion, Isentress, ProQuad, Gardasil, Pneumovax 23, RotaTeq and Belsomra. Merck made its biggest acquisition of Schering-Plough and sold off its Consumer Care business to Bayer. Other key acquisitions include Idenix Pharmaceuticals, Cubist Pharmaceuticals, Rigontec, ArQule and Acceleron Pharma. IMerck spun off products from its Women's Health unit, legacy drugs and biosimilar products into a new publicly traded company called Organon & Co.
Stock Name Country Market Cap PE Ratio
Eli Lilly (LLY) United States $495.141B 66.87
Johnson & Johnson (JNJ) United States $450.090B 16.68
Novo Nordisk (NVO) Denmark $424.453B 49.78
AbbVie (ABBV) United States $264.086B 11.85
AstraZeneca (AZN) United Kingdom $218.471B 19.74
Novartis AG (NVS) Switzerland $218.425B 15.54
Pfizer (PFE) United States $201.199B 7.39
Sanofi (SNY) $132.955B 11.89
Innoviva (INVA) United States $0.953B 10.12